Active Biotech AB Share Price Nasdaq Stockholm
Stocks
ACTI
SE0001137985
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.160 SEK | -0.39% |
|
-1.15% | +12.17% |
| 07-24 | Active Biotech Doses First Patient in Amended Ho172 Clinical Study of Tasquinimod in Myelofibrosis | CI |
| 07-24 | Active Biotech Doses First Patient in Amended Tasquinimod Myelofibrosis Trial | MT |
| Market Cap | 136M 14.3M 12.4M 11.54M 10.6M 20.05M 1.36B 20.36M 53.43M 679M 53.72M 52.54M 2.27B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 136M 14.3M 12.4M 11.54M 10.6M 20.05M 1.36B 20.36M 53.43M 679M 53.72M 52.54M 2.27B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
81.52% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -1.15% | ||
| Current month | -9.79% | ||
| 1 month | -9.79% | ||
| 3 months | -14.85% | ||
| 6 months | +24.04% | ||
| Current year | +12.17% |
| 1 week | 5.06 |  | 5.3 |
| 1 month | 5 | | 5.83 |
| 3 years | 3.7 | | 52.95 |
| 5 years | 3.7 | | 52.95 |
| 10 years | 3.7 | | 427.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helén Tuvesson
CEO | Chief Executive Officer | 64 | 30/06/2017 |
Hans Kolam
DFI | Director of Finance/CFO | 75 | 31/12/1999 |
Erik Vahtola
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/2011 | |
Michael Shalmi
CHM | Chairman | 61 | 22/05/2019 |
Uli Alf Hacksell
BRD | Director/Board Member | 76 | 22/05/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/01/21 | Buy | Director | 24,261 | - | ||
| 25/01/21 | Buy | Director | 525,000 | - | ||
| 25/01/21 | Buy | Director | 935,000 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.39% | -1.15% | -68.88% | -83.13% | 14.3M | |
| +2.35% | +0.77% | +29.92% | +85.38% | 55.23B | |
| -0.21% | -6.52% | +42.39% | +64.10% | 53.75B | |
| -2.44% | -1.61% | -17.69% | -15.68% | 23.48B | |
| -2.85% | -8.20% | -6.26% | +361.83% | 22B | |
| +2.49% | -1.27% | +15.99% | -10.53% | 19.78B | |
| +0.79% | -2.39% | +26.99% | -31.34% | 17.44B | |
| +0.58% | -7.23% | +24.50% | +519.07% | 14.66B | |
| -5.25% | -4.71% | +43.89% | +167.15% | 14.07B | |
| +3.41% | -7.83% | +161.76% | +284.91% | 13.02B | |
| Average | -0.13% | -1.43% | +25.26% | +134.18% | 25.94B | |
| Weighted average by Cap. | +0.17% | +0.09% | +31.04% | +122.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -33.2M -3.49M -3.03M -2.82M -2.59M -4.89M -333M -4.97M -13.04M -166M -13.11M -12.82M -554M | 18.2M 1.91M 1.66M 1.54M 1.42M 2.68M 183M 2.72M 7.15M 90.87M 7.19M 7.03M 304M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | SEK 5.160 | -0.39% | 21,943 |
| 30/07/26 | SEK 5.180 | +0.19% | 12,831 |
| 29/07/26 | SEK 5.170 | +0.39% | 48,621 |
| 28/07/26 | SEK 5.150 | -1.90% | 36,731 |
| 27/07/26 | SEK 5.250 | +0.57% | 47,336 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Net sales - Rate of surprise
- Stock Market
- Stocks
- ACTI Stock
- ACTI Stock
Select your edition
All financial news and data tailored to specific country editions
